Psychiatric disorders in individuals with methamphetamine dependence: Prevalence and risk factors

Metabolic Brain Disease

Volumn 29, Issue 2, 2014, Pages 351-357

  Akindipe, Taiwo ^a   Wilson, Don ^a   Stein, Dan J ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Comorbidity; Methamphetamine; Psychiatric disorders

Indexed keywords

METHAMPHETAMINE;

ADULT; AGORAPHOBIA; ANXIETY DISORDER; ARTICLE; AUDITORY HALLUCINATION; BIPOLAR DISORDER; BIPOLAR NOT OTHERWISE SPECIFIED; COMORBIDITY; DEMOGRAPHY; FEMALE; HUMAN; HYPOMANIA; MAJOR CLINICAL STUDY; MALE; MASCULINITY; MENTAL DISEASE; METHAMPHETAMINE DEPENDENCE; PANIC; PARANOID SCHIZOPHRENIA; POSTTRAUMATIC STRESS DISORDER; PREDICTOR VARIABLE; PREVALENCE; RISK FACTOR; SCHIZOPHRENIFORM DISORDER; SOCIAL PHOBIA; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; STRUCTURED INTERVIEW; CLINICAL TRIAL; DRUG ABUSE; MENTAL DISORDERS; MULTICENTER STUDY; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGY; YOUNG ADULT;

ADULT; AMPHETAMINE-RELATED DISORDERS; COMORBIDITY; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HUMANS; MALE; MENTAL DISORDERS; METHAMPHETAMINE; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 84901623659     PISSN: 08857490     EISSN: 15737365     Source Type: Journal    
DOI: 10.1007/s11011-014-9496-5     Document Type: Article

References (33)

1. Copeland AL, Sorenson JL (2001) Differences between methamphetamine users and cocaine users in treatment. Drug Alcohol Depend 62:91-95 (Pubitemid 32149969)
2. Dalmau A, Bergman B, Brismar B (1999) Psychotic disorders among inpatients with abuse of cannabis, amphetamine and opiates. Do dopaminergic stimulants facilitate psychiatric illness? Eur Psychiatry 14:366-371
3. Diehl DJ, Gershon S (1992) The role of dopamine in mood disorders. Compr Psychiatry 33(2):115-120
4. Farrell M, Marsden J, Ali R, Ling W (2002) Methamphetamine: drug use and psychoses becomes a major public health issue in the Asia Pacific region. Addiction 97:771-772 (Pubitemid 34729087)
5. First MB, Gibbon M, Spitzer RL, Williams JB (2002) Structured clinical interview for DSM-IV-TR axis I disorders. Biometrics Research Department, New York State Psychiatric Institute, 1051 Riverside Drive - Unit 60, New York 10032
6. Glasner-Edwards S, Marinelli-Casey P, Hillhouse M et al (2009) Depression among methamphetamine users: association with outcomes from the methamphetamine treatment project at 3-year follow-up. J Nerv Ment Disord 197:225-231
7. Glasner-Edwards S, Mooney LJ, Marinelli-Casey P et al (2010a) Psychopathology in methamphetamine-dependent adults 3 years after treatment. Drug Alcohol Rev 29(1):12-20
8. Glasner-Edwards S, Mooney LJ, Marinelli-Casey P et al (2010b) Anxiety disorders among methamphetamine dependent adults: association with post-treatment functioning. Am J Addict 19:385-390
9. Herman AA, Stein DJ, Seedat S, Heeringa SG, Moomal H, Williams DR (2009) The South African Stress and Health (SASH) study: 12-month and lifetime prevalence of common mental disorders. S Afr Med J 99:339-344
10. Kalechstein AD, Newton TF, Longshore D et al (2000) Psychiatric comorbidity of methamphetamine dependence in a forensic sample. J Neuropsychiatry Clin Neurosci 12:480-484
11. Katz G, Durst R, Shufman E, Bar-Hamburger R, Grunhaus L (2008) Substance abuse in hospitalized psychiatric patients. Isr Med Assoc J 10:672-675
12. Lee N, Johns L, Jenkinson R, Johnston J, Connolly K et al (2007) Clinical treatment guidelines for alcohol and drug clinicians. No 14: methamphetamine dependence and treatment. Turning Point Alcohol and Drug Centre Inc., Fitzroy
13. McGregor C, Srisurapanont M, Jittiwutikarn J, Laobhripatr S et al (2005) The nature, time course and severity of methamphetamine withdrawal. Addiction 100:1320-1329 (Pubitemid 41248073)
14. McKetin R, McLaren J, Lubman DI, Hides L (2006) The prevalence of psychotic symptoms among methamphetamine users. Addiction 101(10):1473-1478 (Pubitemid 44337772)
15. Moos RH, Nichol AC, Moos BS (2002) Risk factors for symptom exacerbation among treated patients with substance use disorders. Addiction 97:75-85 (Pubitemid 34038195)
16. Murphy DL, Goodwin FK, Brodie KH, Bunney WE (1973) L-dopa, dopamine and hypomania. Am J Psychiatry 130:79-82
17. Parry C, Myers B, Plüddemann A (2004) Drug policy for methamphetamine use urgently needed. S Afr Med J 94:964-965 (Pubitemid 40073727)
18. Plüddemann A, Myers BJ, Parry CDH (2008) Surge in treatment admissions related to methamphetamine use in Cape Town, South Africa: implications for public health. Drug Alcohol Rev 27:185-189
19. Rounsaville BJ, Anton SF, Carroll K, Budde D et al (1991) Psychiatric diagnoses of treatment-seeking cocaine abusers. Arch Gen Psychiatry 48:43-51
20. SACENDU (South African Community Epidemiology Network on Drug Use) (2010) Monitoring alcohol and drug abuse treatment admissions in South Africa. SACENDU Report, Phase 27
21. SACENDU (South African Community Epidemiology Network on Drug Use) (2012) Monitoring alcohol and drug abuse treatment admissions in South Africa. SACENDU Res Brief 15(2):1-15
22. Salo R, Flower K, Kielstein A, Leamon MH et al (2011) Psychiatric comorbidity in methamphetamine dependence. Psychiatr Res 186(2-3):356-361
23. Semple SJ, Zians J, Strathdee SA, Patterson TL (2007) Psychosocial and behavioural correlates of depressed mood among female methamphetamine users. J Psychoactive Drugs Supplement 4:353-366
24. Sheehan DV, Lecrubier Y, Sheehan KH, Janavs J (1997) The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability. Eur Psychiatry 12:232-241 (Pubitemid 27298916)
25. Shoptaw S, Peck J, Reback CJ, Rotheram-Fuller E (2003) Psychiatric and substance dependence co-morbidities, sexually transmitted diseases, and risk behaviours among methamphetamine-dependent gay and bisexual men seeking outpatient drug abuse treatment. J Psychoactive Drugs 35(Suppl 1):161-168 (Pubitemid 36676106)
26. SPSS 20.0 (2012) SPSS Inc., 233 South Wacker Drive, 11th floor, Chicago, IL 606066412
27. Tost H, Alam T, Meyer-Lindenberg A (2010) Dopamine and psychosis: theory, pathomechanisms and intermediate phenotypes. Neurosci Biobehav Rev 34(5):689-700
28. UNODC (United Nations Office on Drugs and Crime) (2005) Patterns and trends in amphetamine-type stimulants in East Asia and the Pacific: findings from the 2004 regional ATS questionnaire. UNODC, Regional Centre for East Asia and the Pacific, Bangkok
29. Vos PJ, Cloete KJ, le Roux A, Kidd M, Jordann GP (2010) A retrospective review of trends and clinical characteristics of methamphetamine-related acute psychiatric admissions in a South African context. Afr J Psychiatry 13:390-394
30. Weiss RD, Mirin SM, Michael JL, Sollogub AC (1986) Psychopathology in chronic cocaine abusers. Am J Drug Alcohol Abuse 12:17-29 (Pubitemid 16061492)
31. Williams DR, Herman A, Stein DJ, Heeringa SG, Jackson PB et al (2008) Twelve-month mental disorders in South Africa: prevalence, service use and demographic correlates in the population-based South African Stress and Health Study. Psychol Med 38(2):211-220 (Pubitemid 351156592)
32. Zorick T, Nestor L, Miotto K, Sugar C et al (2010) Withdrawal symptoms in abstinent methamphetamine-dependent subjects. Addiction 105:1809-1818
33. Zweben JE, Cohen JB, Christian D, Galloway GP et al (2004) Psychiatric symptoms in methamphetamine users. Am J Addict 13(2):181-190 (Pubitemid 38585698)